US equities
|
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
AES
$14.97
▲+0.00%
SNDK
$797.24
▲+0.00%
LLY
$1,415.55
▲+0.00%
AMD
$503.41
▲+0.00%
AAPL
$351.91
▲+0.00%
SPCX
$141.70
▲+0.00%
NVDA
$155.46
▲+0.00%
MU
$712.42
▲+0.00%
AES
$14.97
▲+0.00%
SNDK
$797.24
▲+0.00%
LLY
$1,415.55
▲+0.00%
AMD
$503.41
▲+0.00%
AAPL
$351.91
▲+0.00%
SPCX
$141.70
▲+0.00%
FinancialContent
Sign in
Markets
Overview
News
World markets
Treasuries
Currencies
Commodities
Economy
Stocks
Overview
Most active
Gainers
Losers
Largest companies
52-week gainers
52-week losers
ETFs
Overview
Popular funds
Most active
Gainers
Losers
News
Research
Search
Sectors
Tools
My watchlist
My portfolio
Recent quotes
Latest News about Blood Disorders
Recent news which mentions Blood Disorders
Apellis - Sobi's Pegcetacoplan Wins European Approval For Rare Blood Disorder
December 15, 2021
Tickers
APLS
BIOVF
Tags
Benzinga
General
Briefs
From
Benzinga
EMA's CHMP Backs AstraZeneca's Drug For Rare Blood Disorder In Children
July 26, 2021
Tickers
AZN
AZNCF
Tags
AZNCF
Hedge Funds
Market News
From
Benzinga
BioCryst Outlines Pivotal Trial Designs For BCX9930 In Rare Blood Disorder
July 15, 2021
Tickers
BCRX
Tags
Market News
Briefs
Biotech
From
Benzinga